You are here: Industry Insights > insomnia

News List

Servatus raises $7.5 million to advance autoimmune therapies with its microbial biotherapeutics clinical programs prnasia
December 09, 2021
Servatus Ltd, an unlisted Australian biopharmaceutical company and global expert in the identification and development of novel autoimmune therapies using live microbial biotherapeutics and engineered proteins...
Idorsia submits investigational insomnia treatment daridorexant to the EMA pharmatimes
March 03, 2021
Swiss biotech company Idorsia has submitted a marketing authorisation application to the European Medicines Agency (EMA) for its investigational insomnia treatment daridorexant.
Refined Carbs May Up Insomnia Risk in Postmenopausal Women drugs
December 27, 2019
Diets with a higher glycemic index (GI) may be a risk factor for insomnia in postmenopausal women, according to a study published online December in the American Journal of Clinical Nutrition.
Eisai preps for launch with insomnia med Dayvigo after buying out Purdue fiercepharma
December 27, 2019
Once partners with the now-embattled Purdue on an insomnia treatment, Eisai bought a full stake in the drug earlier this year––taking on its full development and marketing costs, too.
FDA Approves DAYVIGO for Insomnia americanpharmaceuticalreview
December 24, 2019
Eisai announced the U.S. Food and Drug Administration (FDA) approved DAYVIGO™ (lemborexant) 5 mg and 10 mg for the treatment of adult patients with insomnia ...
Genetic Liability to Insomnia Linked to Increased Odds of CVDs drugs
August 20, 2019
Genetic liability to insomnia is associated with increased odds of major cardiovascular diseases, according to a research letter published online in Circulation.
Dr Reddy’s launches insomnia treatment tablets in US expresspharma
July 26, 2019
Drug major Dr Reddy’s Laboratories has said it has launched generic Ramelteon tablets used for treatment of insomnia in the US market. The company has launched Ramelteon tablets in the strength of ...
FDA pushes for stronger warnings on insomnia medicines pharmatimes
May 10, 2019
FDA pushes for stronger warnings on insomnia medicines.
Millions on insomnia drug would sleep through a fire alarm europeanpharmaceuticalreview
April 12, 2019
A study has reported that millions currently taking benzodiazepines to help them sleep would not hear a fire alarm, thus warning of possible dangers…
Eisai and Purdue Pharma seek US approval for lemborexant to treat insomnia pharmaceutical-technology
January 17, 2019
Eisai and its partner Purdue Pharma have submitted new drug application to the US Food and Drug Administration (FDA) seeking approval for lemborexant to treat insomnia, a sleep disorder.....

Previous page 1 2 Next page